Does BRIGATINIB Cause Therapy partial responder? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Therapy partial responder have been filed in association with BRIGATINIB (Alunbrig). This represents 0.3% of all adverse event reports for BRIGATINIB.
9
Reports of Therapy partial responder with BRIGATINIB
0.3%
of all BRIGATINIB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Therapy partial responder From BRIGATINIB?
Of the 9 reports, 1 (11.1%) resulted in death.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRIGATINIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does BRIGATINIB Cause?
Death (405)
Non-small cell lung cancer (370)
Off label use (256)
Diarrhoea (239)
Metastases to central nervous system (219)
Nausea (218)
Lung neoplasm malignant (216)
Fatigue (201)
Blood creatine phosphokinase increased (198)
Product dose omission issue (193)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which BRIGATINIB Alternatives Have Lower Therapy partial responder Risk?
BRIGATINIB vs BRILINTA
BRIGATINIB vs BRILIQUE
BRIGATINIB vs BRIMONIDINE
BRIGATINIB vs BRIMONIDINE\BRINZOLAMIDE
BRIGATINIB vs BRIMONIDINE\TIMOLOL